The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months
Open accessAbstract
Purpose: To describe the content and potentials of the new Swedish national register on prescribed and dispensed medicines. Methods: The Swedish Prescribed Drug Register contains information about age, sex and unique identifier of the patient as well as the prescriber's profession and practice. Information regarding drug utilization and expenditures for prescribed drugs in the entire Swedish population was extracted from the first six months July–December 2005 and compared with total drug sales in the country including OTC and hospital use. Results: The total quantity of drugs sold in Sweden was 2666 million DDDs, corresponding to 1608 DDD/1000 inhabitants daily. The total expenditures were 1.6 billion Euro. The prescribed drugs, included in the register, accounted for 84% of the total utilization and 77% of the total expenditures. About half of all men and two‐thirds of all women in the country purchased drugs. The proportion increased by age. The most common drugs for chronic treatment were diuretics among women (8.8% of the population) and antithrombotic agents among men (7.6%). Psychotropic drugs, corticosteroids and analgesics were more common among women, while men used antithrombotic agents, antidiabetic drugs, lipid lowering agents and ACE inhibitors to a greater extent. Conclusions: The new register provides valuable data on exposure to drugs and is useful to study patterns of drug utilization. The possibilities for record linkage to other health registers gives from an international perspective good opportunities to explore drug and disease associations and the risks, benefits, effectiveness and health economical effects of drug use. Copyright © 2006 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The Swedish Prescribed Drug Register provides complete data on dispensation of prescription medications from all pharmacies since July 2005.
“The Swedish Prescribed Drug Register provides complete data on dispensation of prescription medications from all pharmacies since July 2005 [27].”
From Antidepressant use and cognitive decline in patients with dementia: a national cohort study (2025) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
When are observational studies as credible as randomised trials?
Vandenbroucke, J. P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16261-2 · Cited by 538 · cited 1×
“There are many examples of randomised clinical trials failing to confirm effects or adverse events found in observational studies.(30) Without any randomization, it is difficult to distinguish between effects of drugs and patients disease history.”
Background
Flagged first, then by citations
Research works printed but not linked: 31
- Strom B, 2005, Pharmacoepidemiology
- 10.1016/0895-4356(92)90092-2 · DOI
- Bergström K, 1971, Psychiatry. V World Congress of Psychiatry, Mexico
- 10.1007/BF00561402 · DOI
- 10.1016/0021-9681(87)90101-9 · DOI
- Bergman U, 2001, Pharmacoepidemiology—from description to quality assessment. A Swedish perspective, Norwegian Journal of Epidemiology, 11, 31
- National Board of Health and Welfare, 2003, Monitoring public health and social conditions in Sweden 1992–2002
- 10.1016/0168-8510(94)90050-7 · DOI
- Bergman U, 1984, Measurement of drug utilization in Sweden: methodological and clinical implications, Acta Medica Scandinavia, 105, 15, 10.1111/j.0954-6820.1984.tb08709.x · DOI
- 10.1034/j.1600-0404.2001.00197.x · DOI
- 10.1002/pds.624 · DOI
- Wettermark B, 2001, Har vi råd med en bra kolesterolsänkande behandling? Budgetunderlag för behovsbaserade statinkostnader i Stockholms län [Can we afford good cholesterol lowering therapy? Budgeting of statin costs versus medical needs in the county of Stockholm], Läkartidningen, 98, 5472
- 10.1002/pds.1154 · DOI
- 10.1136/heart.88.3.229 · DOI
- 10.1001/jama.279.18.1458 · DOI
- 10.1111/j.1365-2125.2005.02355.x · DOI
- 10.1046/j.1365-2125.2000.00192.x · DOI
- 10.1007/s002280050360 · DOI
- 10.1016/S0301-2115(00)00388-2 · DOI
- 10.1016/j.reprotox.2005.01.010 · DOI
- 10.1002/pds.580 · DOI
- 10.1375/1369052012155 · DOI
- 10.1111/j.1365-2710.1992.tb01306.x · DOI
- 10.1001/jama.287.3.337 · DOI · Paper page
- SundströmA JanssonK WiholmBE.The CCNET Control‐Pool: a database of 2000 randomly selected community controls in Sweden. Abstract presented at the ‘8th Annual Meeting—European Society of Pharmacovigilance’ Verona September2000. Conference‐book edited by Giampaolo Velo and Roberto Leone (Elsevier).
- 10.1002/pds.1082 · DOI
- 10.1002/pds.627 · DOI
- 10.1136/bmj.328.7451.1300 · DOI
- Klaukka T, 2001, The Finnish database on drug utilisation, Norwegian Journal of Epidemiology, 11, 19
- Strøm H, 2004, Reseptbasert legemiddelregister: Et viktig verktøy for å oppnå detaljert legemiddelstatistikk, (Article in Norwegian) Norsk Epidemiologi, 14, 53
- Gaist D, 1997, The Danish prescription registries, Dan Med Bull, 44, 445
Cited by
Sorted by citations
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
Jernberg, T., Hasvold, P., Henriksson, M., Hjelm, H., Thuresson, M., & Janzon, M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu505 · Cited by 875
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
Simon, T. G., Roelstraete, B., Khalili, H., Hagström, H., & Ludvigsson, J. F. (2021) · Gut · doi:10.1136/gutjnl-2020-322786 · Cited by 673
Medication for Attention Deficit–Hyperactivity Disorder and Criminality
Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203241 · Cited by 611
Jonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412
Larsson, H., Chang, Z., D'Onofrio, B. M., & Lichtenstein, P. (2014) · Psychological Medicine · doi:10.1017/s0033291713002493 · Cited by 364
Chang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjölander, A., & Larsson, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4174 · Cited by 293
Arnheim-Dahlstrom, L., Pasternak, B., Svanstrom, H., Sparen, P., & Hviid, A. (2013) · BMJ · doi:10.1136/bmj.f5906 · Cited by 279
Autism Spectrum Disorders in the Stockholm Youth Cohort: Design, Prevalence and Validity
Idring, S., Rai, D., Dal, H., Dalman, C., Sturm, H., Zander, E., Lee, B. K., Serlachius, E., & Magnusson, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041280 · Cited by 275
Adverse Childhood Experiences and Adult Mental Health Outcomes
Daníelsdóttir, H. B., Aspelund, T., Shen, Q., Halldorsdottir, T., Jakobsdóttir, J., Song, H., Lu, D., Kuja-Halkola, R., Larsson, H., Fall, K., et al. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.0039 · Cited by 266
Boden, R., Lundgren, M., Brandt, L., Reutfors, J., Andersen, M., & Kieler, H. (2012) · BMJ · doi:10.1136/bmj.e7085 · Cited by 245
Viktorin, A., Lichtenstein, P., Thase, M. E., Larsson, H., Lundholm, C., Magnusson, P. K. E., & Landén, M. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13111501 · Cited by 246
The familial co-aggregation of ASD and ADHD: a register-based cohort study
Ghirardi, L., Brikell, I., Kuja-Halkola, R., Freitag, C. M., Franke, B., Asherson, P., Lichtenstein, P., & Larsson, H. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.17 · Cited by 220
Stimulant ADHD medication and risk for substance abuse
Chang, Z., Lichtenstein, P., Halldner, L., D'Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12164 · Cited by 225
“We also used the Prescribed Drug Register, which included information on all prescribed medical drugs since July 2005 (Wettermark et al., 2007).”
Ekström, N., Schiöler, L., Svensson, A.-M., Eeg-Olofsson, K., Miao Jonasson, J., Zethelius, B., Cederholm, J., Eliasson, B., & Gudbjörnsdottir, S. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001076 · Cited by 221
Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
Nilsson, E., Gasparini, A., Ärnlöv, J., Xu, H., Henriksson, K. M., Coresh, J., Grams, M. E., & Carrero, J. J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.035 · Cited by 211
Brusselaers, N., Wahlin, K., Engstrand, L., & Lagergren, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017739 · Cited by 204
Simon, T. G., Roelstraete, B., Sharma, R., Khalili, H., Hagström, H., & Ludvigsson, J. F. (2021) · Hepatology · doi:10.1002/hep.31845 · Cited by 176
Antibiotic exposure and the development of coeliac disease: a nationwide case–control study
Mårild, K., Ye, W., Lebwohl, B., Green, P. H., Blaser, M. J., Card, T., & Ludvigsson, J. F. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-109 · Cited by 175
Chen, Q., Sjolander, A., Runeson, B., D'Onofrio, B. M., Lichtenstein, P., & Larsson, H. (2014) · BMJ · doi:10.1136/bmj.g3769 · Cited by 170
Hirvikoski, T., Boman, M., Chen, Q., D'Onofrio, B. M., Mittendorfer-Rutz, E., Lichtenstein, P., Bölte, S., & Larsson, H. (2020) · Psychological Medicine · doi:10.1017/s0033291719001405 · Cited by 157
Chang, Z., D’Onofrio, B. M., Quinn, P. D., Lichtenstein, P., & Larsson, H. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.018 · Cited by 154
Song, J., Sjölander, A., Joas, E., Bergen, S. E., Runeson, B., Larsson, H., Landén, M., & Lichtenstein, P. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16050542 · Cited by 147
Skoglund, C., Chen, Q., D′Onofrio, B. M., Lichtenstein, P., & Larsson, H. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12124 · Cited by 136
Ljung, T., Chen, Q., Lichtenstein, P., & Larsson, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.363 · Cited by 132
Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults
Johnell, K., Jonasdottir Bergman, G., Fastbom, J., Danielsson, B., Borg, N., & Salmi, P. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4483 · Cited by 130
Larsson, H., Sariaslan, A., Långström, N., D'Onofrio, B., & Lichtenstein, P. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12140 · Cited by 126
The societal cost of depression: Evidence from 10,000 Swedish patients in psychiatric care
Ekman, M., Granström, O., Omérov, S., Jacob, J., & Landén, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.03.003 · Cited by 101
GLP-1 Receptor Agonist Use and Risk of Suicide Death
Ueda, P., Söderling, J., Wintzell, V., Svanström, H., Pazzagli, L., Eliasson, B., Melbye, M., Hviid, A., & Pasternak, B. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.4369 · Cited by 103
Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Reutfors, J., Andersson, T. M.-L., Brenner, P., Brandt, L., DiBernardo, A., Li, G., Hägg, D., Wingård, L., & Bodén, R. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.030 · Cited by 94
Giacobini, M., Medin, E., Ahnemark, E., Russo, L. J., & Carlqvist, P. (2018) · Journal of Attention Disorders · doi:10.1177/1087054714554617 · Cited by 94
Brikell, I., Ghirardi, L., D’Onofrio, B. M., Dunn, D. W., Almqvist, C., Dalsgaard, S., Kuja-Halkola, R., & Larsson, H. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.006 · Cited by 85
Mollazadegan, K., Kugelberg, M., Montgomery, S. M., Sanders, D. S., Ludvigsson, J., & Ludvigsson, J. F. (2013) · Diabetes Care · doi:10.2337/dc12-0766 · Cited by 82
Prevalence of severe childhood asthma according to the WHO
Nordlund, B., Melén, E., Schultz, E. S., Grönlund, H., Hedlin, G., & Kull, I. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.05.015 · Cited by 79
Skoglund, C., Sundström Poromaa, I., Leksell, D., Ekholm Selling, K., Cars, T., Giacobini, M., Young, S., & Kopp Kallner, H. (2024) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13920 · Cited by 77
Björkenstam, E., Björkenstam, C., Jablonska, B., & Kosidou, K. (2018) · Psychological Medicine · doi:10.1017/s0033291717001933 · Cited by 73
Ludvigsson, J. F., Olén, O., Larsson, H., Halfvarson, J., Almqvist, C., Lichtenstein, P., & Butwicka, A. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab039 · Cited by 76
Zheng, D., Li, N., Hou, R., Zhang, X., Wu, L., Sundquist, J., Sundquist, K., & Ji, J. (2023) · BMC Medicine · doi:10.1186/s12916-023-02753-6 · Cited by 74
Attention-Deficit/Hyperactivity Disorder and Risk for Substance Use Disorders in Relatives
Skoglund, C., Chen, Q., Franck, J., Lichtenstein, P., & Larsson, H. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.006 · Cited by 70
Björnsdottir, S., Sundström, A., Ludvigsson, J. F., Blomqvist, P., Kämpe, O., & Bensing, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3561 · Cited by 70
Self-citationHollis, C., Chen, Q., Chang, Z., Quinn, P. D., Viktorin, A., Lichtenstein, P., D'Onofrio, B., Landén, M., & Larsson, H. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30189-0 · Cited by 65
Forslund, T., Kosidou, K., Wicks, S., & Dalman, C. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02749-z · Cited by 63
Perinatal depression and risk of mortality: Nationwide, register-based study in Sweden
Hagatulah, N., Bränn, E., Oberg, A. S., Valdimarsdóttir, U. A., Shen, Q., & Lu, D. (2024) · BMJ · doi:10.1136/bmj-2023-075462 · Cited by 72
Statin use is associated with improved outcomes of patients with primary sclerosing cholangitis
Stokkeland, K., Höijer, J., Bottai, M., Söderberg-Löfdal, K., & Bergquist, A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.11.002 · Cited by 63
Autism risk following antidepressant medication during pregnancy
Viktorin, A., Uher, R., Reichenberg, A., Levine, S. Z., & Sandin, S. (2017) · Psychological Medicine · doi:10.1017/s0033291717001301 · Cited by 62
Skoglund, C., Kopp Kallner, H., Skalkidou, A., Wikström, A.-K., Lundin, C., Hesselman, S., Wikman, A., & Sundström Poromaa, I. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.12463 · Cited by 67
Petek, B., Häbel, H., Xu, H., Villa-Lopez, M., Kalar, I., Hoang, M. T., Maioli, S., Pereira, J. B., Mostafaei, S., Winblad, B., et al. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01360-0 · Cited by 65
Ebrahimi, F., Hagström, H., Sun, J., Bergman, D., Shang, Y., Yang, W., Roelstraete, B., & Ludvigsson, J. F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.018 · Cited by 65
Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study
Lagerberg, T., Fazel, S., Sjölander, A., Hellner, C., Lichtenstein, P., & Chang, Z. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01179-z · Cited by 61
Tang, B., Sjölander, A., Wastesson, J. W., Maura, G., Blotiere, P.-O., Szilcz, M., Mak, J. K. L., Qin, C., Alvarsson, M., Religa, D., et al. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102689 · Cited by 57
Viktorin, A., Uher, R., Kolevzon, A., Reichenberg, A., Levine, S. Z., & Sandin, S. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1727 · Cited by 45
Fornes, R., Simin, J., Nguyen, M. H., Cruz, G., Crisosto, N., van der Schaaf, M., Engstrand, L., & Brusselaers, N. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00905-6 · Cited by 44
Severe head injury and amyotrophic lateral sclerosis
Peters, T. L., Fang, F., Weibull, C. E., Sandler, D. P., Kamel, F., & Ye, W. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2012.754043 · Cited by 45
Antidepressant use and cognitive decline in patients with dementia: a national cohort study
Mo, M., Abzhandadze, T., Hoang, M. T., Sacuiu, S., Jurado, P. G., Pereira, J. B., Naia, L., Kele, J., Maioli, S., Xu, H., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-03851-3 · Cited by 45
Nylander, L., Axmon, A., Björne, P., Ahlström, G., & Gillberg, C. (2018) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-018-3567-0 · Cited by 43
Du Rietz, E., Jangmo, A., Kuja‐Halkola, R., Chang, Z., D'Onofrio, B. M., Ahnemark, E., Werner‐Kiechle, T., & Larsson, H. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13206 · Cited by 39
Ahlberg, R., Du Rietz, E., Ahnemark, E., Andersson, L. M., Werner-Kiechle, T., Lichtenstein, P., Larsson, H., & Garcia-Argibay, M. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04713-z · Cited by 27
Lim, C.-E., Pasternak, B., Eliasson, B., & Ueda, P. (2025) · Diabetologia · doi:10.1007/s00125-025-06439-x · Cited by 27
Viktorin, A., Levine, S. Z., Altemus, M., Reichenberg, A., & Sandin, S. (2018) · BMJ · doi:10.1136/bmj.k2233 · Cited by 23
Ghirardi, L., Chen, Q., Chang, Z., Kuja‐Halkola, R., Skoglund, C., Quinn, P. D., D'Onofrio, B. M., & Larsson, H. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13136 · Cited by 20
Overuse of methylphenidate: an analysis of Swedish pharmacy dispensing data
Bjerkeli, P. J., Perez Vicente, R., Mulinari, S., Johnell, K., & Merlo, J. (2018) · Clinical Epidemiology · doi:10.2147/clep.s178638 · Cited by 18
Furster, C., & Hallerbäck, M. U. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1866-3 · Cited by 19
Mourtzinis, G., Manhem, K., Kahan, T., Schiöler, L., Isufi, J., Ljungman, C., Andersson, T., & Hjerpe, P. (2021) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2021.2004841 · Cited by 15
Chen, E. Y., Dahlén, T., Stenke, L., Björkholm, M., Hao, S., Dickman, P. W., & Clements, M. S. (2025) · European Journal of Haematology · doi:10.1111/ejh.14328 · Cited by 13
Celiac Disease Does Not Influence Fracture Risk in Young Patients with Type 1 Diabetes
Reilly, N. R., Lebwohl, B., Mollazadegan, K., Michaëlsson, K., Green, P. H. R., & Ludvigsson, J. F. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.10.032 · Cited by 10
Metadata
- Authors
- Wettermark, B., Hammar, N., MichaelFored, C., Leimanis, A., Otterblad Olausson, P., Bergman, U., Persson, I., Sundström, A., Westerholm, B., & Rosén, M.
- Affiliations
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- National Board of Health and Welfare (SE)
- Medical Products Agency (SE)
- Corresponding author
- Wettermark, Björn
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2006-08-09
- Volume
- 16
- Issue
- 7
- Pages
- 726-735
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2168021466
- Cited by
- 1,887
- References
- 1
- Citations by year
- 2026: 123 · 2025: 170 · 2024: 162 · 2023: 148 · 2022: 113 · 2021: 162 · 2020: 152 · 2019: 146 · 2018: 101 · 2017: 108 · 2016: 95 · 2015: 82 · 2014: 80 · 2013: 80 · 2012: 45
- FWCI
- 18.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Pharmacoepidemiology and Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Health Information Management › Medical Coding and Health Information
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- medication use, drug expenditure, sex differences in drug use, age differences in drug use, chronic disease treatment, data linkage
- MeSH terms
- Adolescent, Adult, Aged, Child, Child, Preschool, Commerce, Drug Utilization, Epidemiologic Methods, Health Expenditures, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Practice Patterns, Physicians', Drug Prescriptions, Registries, Sweden, Drug Costs, Pharmacoepidemiology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
